Researchers in Cincinnati are developing groundbreaking AI Technology that can potentially revolutionize women’s Health screenings by detecting heart disease. This innovation, being developed by Genexia Health, a startup company, uses a specialized algorithm that analyzes mammogram images to diagnose the risk of heart disease.
It is reported that this AI technology is expected to be available by 2027, pending FDA approval. The co-founder of Genexia Health, Kelly Cohen, who himself survived a heart attack, highlights the importance of early detection in saving lives. Cohen emphasizes that women, in particular, may not exhibit obvious symptoms of heart disease, making early detection crucial.
The AI software, designed to be integrated into routine mammograms, aims to proactively identify coronary artery disease in women who may have gone undiagnosed. This innovative approach has the potential to provide early intervention and improve outcomes for patients.
Currently undergoing testing at University Hospitals in Cleveland, the technology is expected to receive widespread approval and usage in the coming years. Dino Martis, CEO of Genexia Health, affirms the uniqueness of this technology, stating that it is the first of its kind in the world.
As efforts continue to expand the availability of this groundbreaking technology, the hope is to provide individuals with the ability to detect and address heart health issues before they escalate. With the potential to make a significant impact on people’s lives, this AI innovation represents a major step forward in preventive healthcare.
Read More Technology News
